COMMUNIQUÉS West-GlobeNewswire

-
Sironax Announces Key Leadership Appointments to Advance Global Drug Discovery and Development
22/10/2025 -
Kyverna Therapeutics to Host Conference Call on Interim Phase 2 Data from KYSA-6 Study of KYV-101 in Generalized Myasthenia Gravis
22/10/2025 -
New Heartflow PCI Navigator to Equip Interventional Cardiologists with Pre-procedural Insights to Enable PCI Planning
22/10/2025 -
Madrigal Pharmaceuticals to Release Third-Quarter 2025 Financial Results and Host Webcast on November 4, 2025
22/10/2025 -
Vera Therapeutics to Host an Investor Call and Webcast to Provide an ORIGIN 3 Update on November 6, 2025 at 4:30 pm ET
22/10/2025 -
Turn Therapeutics Provides Shareholder Update Highlighting Continued Execution Across Clinical and Strategic Milestones
22/10/2025 -
Equillium to Host Ulcerative Colitis KOL Event on November 5, 2025
22/10/2025 -
Cassava Sciences Appoints Dawn C. Bir to the Board of Directors
22/10/2025 -
The Future of Discovery: Science News Spotlights Scientists to Watch
22/10/2025 -
Catalyst Pharmaceuticals to Report Third Quarter 2025 Financial Results on November 5, 2025
22/10/2025 -
Vivani Medical to Present at the ThinkEquity Conference on October 30, 2025
22/10/2025 -
Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) Stands Out with Proprietary Next-Gen Breast CT Imaging System
22/10/2025 -
Profusa Expands Sales Footprint with New Distributor for Lumee™ Oxygen Platform in Europe
22/10/2025 -
24/7 Market News- Kraig Labs Scalable Spider Silk May Unlock the Future of Lightweight Body Armor and Ballistic Protection
22/10/2025 -
Fulcrum Therapeutics to Host Third Quarter 2025 Financial Results Conference Call and Webcast on Wednesday, October 29, 2025, at 8:00 a.m. ET
22/10/2025 -
Wake-Up Call: Aeroflow Sleep Survey Reveals a Growing Gap in Sleep Health Education and the Rise of DIY Sleep Trends
22/10/2025 -
Aeroflow Health Wins 2025 HME Provider of the Year Award
22/10/2025 -
Elevara Medicines Raises $70 Million Series A to Advance Phase 2 Rheumatoid Arthritis Trial and Expand Pipeline
22/10/2025 -
Onco3R Therapeutics reports first pre-clinical data from its best-in-class precision oncology portfolio at the 2025 AACR-NCI-EORTC symposium
22/10/2025
Pages